Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3075)	9/7/2010 12:16:11 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SOMX has closed most of its Aug25 UG and today is trading above $4 up 4.18% on volume 1M > its ADV bigcharts.marketwatch.com It announced today that Silenor is now commercially available by prescription in the United States. Somaxon has implemented a wholesale and retail stocking program to disseminate Silenor 3 mg and 6 mg dosepacks to pharmacies across the United States. Silenor,is the first and only prescription product approved for the treatment of sleep maintenance insomnia that is not a controlled substance. The stock is starting to get off from the DT coming from the H of the March 19 spike, when the stock traded as H as $10.60 <g> bigcharts.marketwatch.com SOMX has been trimming its losses in the last 4Qs, but the analysts are expecting a loss for 2010 around $1.08 vs. $0.69 in 2009 However, the ACTAY is $11 As mentioned, the stock has resistance at $6, but if losses in the pending 2Qs come out less than expected, it is possible that the stock could hit my revised TT at $8 <g> bigcharts.marketwatch.com Bernard